Seroprevalence of Leishmania infection among asymptomatic renal transplant recipients from southern Spain
Metadata
Show full item recordAuthor
Elmahallawy, Ehab Kotb; Cuadros-Moronta, E.; Liébana Martos, María del Carmen; Rodríguez-Granger, Javier Moises; Sampedro-Martínez, Antonio; Agil Abdalla, Mhmad Ahmad; Navarro Marí, José María; Bravo Soto, Juan; Gutiérrez Fernández, JoséEditorial
Wiley
Materia
Seroprevalence Leishmaniasis Renal transplant recipient
Date
2015-12Referencia bibliográfica
Elmahallawy et al. Leishmania in renal transplant. Transplant Infectious Disease 2015: 17: 795–799. DOI: 10.1111/tid.12444
Sponsorship
Erasmus Mundus Scholarship Program (ELEMENT Action 1 First call)Abstract
Background: The aim of this article is to assess the seroprevalence of Leishmania infection among asymptomatic renal transplant recipients in a population in the south of Spain.
Methods: Serum samples were screened for immunoglobulin-G antibodies against Leishmania with an indirect fluorescent antibody test.
Results: Of 625 examined serum samples, 30 (4.8%) samples were positive for Leishmania antibodies. Thirteen samples showed titers of 1:80, 15 samples showed titers of 1:160, and 2 samples showed titers of 1:320. None of the patients with positive serology to Leishmania showed signs or symptoms compatible with leishmaniasis.
Conclusion: The prevalence of Leishmania infection found among asymptomatic renal transplant patients reinforces the need for attention in evaluation of these patients in endemic areas.